Oncotarget is a peer-reviewed medical journal published weekly on an open access platform. It covers scholarly research on the issue about oncology. Impact journals launched Oncotarget in 2010. Andrei Gudkov and Mikhail Blagosklonny are the editors-in-chief of Oncotarget. The journal particularly publishes findings on the pathogenesis of all forms of cancers, potential therapy targets, and protocols for treatment used to improve cancer management in patients. It further publishes studies on results of management therapy and newly developed therapeutic agents as well as patient perspectives protocols including adherence, life quality, and satisfaction. Oncotarget also examines evidence that explains new and current therapies about the improvement of results, and application in respect to acceptance and uptake by healthcare experts and patients. Follow Oncotarget on Twitter.
The popularity of Oncotarget is on the rise mainly driven by helpful, insightful, multiple peer-reviews that increase the influence of author’s findings. The journal is also a mainstream multidisciplinary literature freely accessible to readers. Its mission is to accelerate and broaden the availability of scientific findings and thereby optimize the effect of research through intuitive review. The journal further facilitates and quickens sharing of groundbreaking discoveries in sciences. It also eliminates barriers between experts for interlink of various biomedical science disciplines. Oncotarget further promotes the application of clinical and natural science to the fight against diseases. It brings onboard authoritative experts to help in the development of science for the world with no diseases.
Among the latest Oncotarget’s publications include its publication of a study by University of Rochester Medical Center, which proofs that electronic cigarettes inflict similar damage to gums and teeth as ordinary cigarettes. UR School of Medicine and Dentistry professor Irfan Rahman led the groundbreaking study on the detrimental impact of e-cigarettes on oral health at molecular and cellular levels. The study followed a growing popularity of e-cigarettes amongst new adults as well as former and current smokers due to the misconception that e-cigarette is a healthier substitute to an ordinary cigarette. The findings dismissed earlier attribution of the harmful effect of cigarette to its smoke. It demonstrated that the burning of e-cigarette vapors leads to secretion of inflammatory proteins, which consequently worsens the cells’ stress causing damage that cause myriads of oral diseases. The findings illustrate the innovative contribution of Oncotarget to the fight against diseases.